The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
8 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,440,739 in first-year total cost, median $504,298.
Most frequent study sections
- Cancer Biomarkers Study Section[CBSS]5
- Molecular Cancer Diagnosis and Classification Study Section[MCDC]3
Most frequent institutions
- BECKMAN RESEARCH INSTITUTE/CITY OF HOPE1
- OHIO STATE UNIVERSITY1
- OREGON HEALTH & SCIENCE UNIVERSITY1
- UNIVERSITY OF CALIFORNIA LOS ANGELES1
- UNIVERSITY OF KANSAS MEDICAL CENTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2023 | Exosomal biomarkers for the early detection of hepatocellular carcinoma1R01CA271443-01A1 | GOEL, AJAY | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | $745,286 | MCDC |
| 2023 | The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection1R01CA272766-01A1 | GASTON, SANDRA MPOLLACK, ALANPUNNEN, SANOJ | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $520,290 | MCDC |
| 2023 | Application of 4D proteomics and super-resolution microscopy in extracellular vesicle and particle-borne biomarker discovery for early pancreatic cancer detection2R01CA218513-06A1 | GERI, JACOBLYDEN, DAVID CHARLESZHANG, HAIYING | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $488,306 | MCDC |
| 2023 | A SYNTHETIC BIOMARKER TO UNIVERSALLY ASSESS THE RELATIVE CONTRIBUTION OF HEATHY AND CANCEROUS TISSUE TO CIRCULATING EV POOL1R01CA270251-01A1 | COCUCCI, EMANUELE | OHIO STATE UNIVERSITY, OH | $433,128 | CBSS |
| 2022 | Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers1R37CA258787-01A1 | IBSEN, STUART DUNCAN | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $471,675 | CBSS |
| 2022 | Universal Internal Standard for Reproducible Accurate Quantification of Exosome Protein Markers1R01CA258240-01A1 | LUBMAN, DAVID M.SHI, TUJIN | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $466,913 | CBSS |
| 2021 | Extracellular Vesicle-Based Digital Scoring Assay for Detecting Early-stage Hepatocellular Carcinoma1R01CA255727-01 | ZHU, YAZHEN | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $659,686 | CBSS |
| 2021 | Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem1R01CA260132-01 | GODWIN, ANDREW K.ZENG, YONG | UNIVERSITY OF KANSAS MEDICAL CENTER, KS | $655,455 | CBSS |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.